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Introduction 
Over the past 50 years, deaths from liver disease have risen dramatically, whereas deaths 
from many other major diseases have fallen (Williams et al, 2014). Liver disease is now the 
third largest cause of premature death in the UK, with alcohol related liver disease accounting 
for nearly 40% of these deaths (National End of Life Care Intelligence Network (NELCIN), 
2012). With advanced liver disease comes the associated complications of varices, hepatic 
encephalopathy and ascites, and death from liver disease can be sudden and catastrophic. 
It has been acknowledged that ‘supportive and palliative care needs in people with liver 
disease often go unrecognised and unaddressed’ (Kimbell et al, 2018). End-of-life care and 
wishes can be a difficult subject to broach to patients and their loved ones, but it is one that 
nurses are often best placed to undertake. Therefore, when considering the overall care of 
patients with liver disease, it is necessary to incorporate anticipatory and concordant end-of-
life plans. 
Liver death rates 
Since the 1970s, death rates from liver disease have exponentially increased by over 
400%, whereas death rates from other causes have lowered (Public Health England (PHE), 
2018). Between 2001 and 2009 alone, there was a 25% increase in liver-related deaths in the 
UK, and in 2014 there were approximately 11 600 deaths attributable to liver disease (PHE, 
2018). Liver disease is now the fifth biggest cause of death in the UK, making it the only major 
cause of death that is continuing to increase year on year (British Liver Trust (BLT), 2017; 
Williams et al, 2018). There are many causes of liver disease, but the main attributable factors 
are alcohol, obesity and viral hepatitis. All of these are preventable (NELCIN, 2012). Other 
factors include the genetic conditions haemochromatosis and autoimmune liver disease. 
Liver disease in the under 65s is now the third major cause of premature death, with 
alcohol-related liver disease accounting for around 37% of all liver deaths (NELCIN, 2012). 
Because of this, being diagnosed with or dying from liver disease is often associated with a 
stigma. Furthermore, the increasing incidence of advanced liver disease presents a major 
public health issue and potential palliative burden to the health service (Faull et al, 2012). 
Complications of liver disease  
Liver cirrhosis leads to portal hypertension, which carries the complications of ascites, 
varices and hepatic encephalopathy (HE).  
Varices 
Variceal haemorrhage is a major cause of mortality and one of the most distressing 
complications for patients to experience or loved ones to witness (National Institute for Health 
and Care Excellence (NICE), 2013). Therefore, people dying from liver disease can have 
complex end-of-life care needs that require hospital admission to deal with complications. 
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Around 70% of these patients die in hospital (NELCIN, 2012). This can make end-of-life 
discussions and planning challenging. However, these discussions can be even more difficult 
for those with alcohol-related liver disease, who are often younger and, in some instances, 
compounded with drug dependence and/or mental health problems, with no social or family 
support (PHE, 2017). 
Hepatic encephalopathy 
Hepatic encephalopathy is a complication of decompensated liver cirrhosis and manifests 
as altered levels of consciousness, ranging from forgetfulness through to confusion and, in 
severe cases, coma. HE is graded from 0–4 (Table 1). HE can occur suddenly, and its 
manifestation can be alarming. Therefore, patients and their loved ones should be forewarned 
of the potential complications of liver disease before they occur. 
 




Changes to mentation and affect (such as reduced coordination or 
concentration); no clinical evidence 
Grade 1 
(mild) 




Forgetfulness; fatigue; slurred speech; inability to do basic arithmetic; 
apparent confusion; ability to respond to verbal commands 
Grade 3 
(severe) 
Confusion; bizarre behaviour; sleepiness; responsiveness to verbal stimuli 
Grade 4 
(coma) 
Coma; potential irresponsiveness to painful stimuli 
Source: European Association for the Study of the Liver (2010) 
 
Ascites 
Ascites is the abnormal accumulation of fluid within the peritoneal cavity. There are many 
causes of ascites, but it is most commonly due to cirrhosis of the liver causing portal 
hypertension (Douglas et al, 2013). The development of ascites is an indicator that liver 
cirrhosis has progressed from compensated (or stable) cirrhosis to decompensated cirrhosis 
(BLT, 2017), which is a sign of end-stage liver disease. Many litres of fluid can accumulate in 
the peritoneal cavity, causing discomfort and pain, as well as more serious complications, 
such as breathing difficulties, hydrothorax and spontaneous bacterial peritonitis. For patients 
with decompensated liver disease, if liver transplantation is not an option, this is an appropriate 
time to discuss advance care planning. Patients with decompensated cirrhosis have a 40% 




Prognosis and scoring systems 
Prognosis is closely related to the severity of the underlying disease. In the complex 
management of such an array of symptoms, it is possible to predict survival rates and disease 
trajectories with the support of well-established scoring classifications, such as the Childs-
Pugh classification, the model for end-stage liver disease (MELD) and the UK end-stage liver 
disease (UKELD) model (Medici et al, 2008). 
The MELD scoring system is primarily used to predict mortality for patients on a waiting list 
for liver transplant. However, studies have revealed adding serum sodium to the MELD 
scoring system, as in UKELD, provides a better prognostic indicator of mortality before and 
after liver transplantation (Aroori et al, 2010). Hepatology units use both the Child-Pugh 
scoring systems and the UKELD score to determine priority for liver transplantation (Cheung 
and Cheung, 2013). The Child-Pugh score uses clinical features, such as: 
• Serum levels of bilirubin 
• International normalised ratio (INR) 
• Degree of ascites 
• Grade of HE. 
 While increasing symptom burden does correlate with increasing disease severity, sudden 
changes in symptoms and the speed of deterioration can create much uncertainty for patients 
living with advanced liver disease and those managing their care (Kimbell et al, 2015). 
However, uncertainty neither explains nor excuses professional failure to have timely 
conversations about the future with patients with advancing liver disease. In fact, prognostic 
indicators should enable timely conversations, and best-practice guidance encourages carers 
to be proactive towards conversations about their future care, wishes and preferences (Wright 
et al, 2018). 
Timely identification of patients 
In view of liver disease’s increasing symptom burden and palliative care needs, which can 
go unrecognised, patients with advancing disease need to be identified in a timely manner 
(Poonja et al, 2014). To ensure care, assessment and planning are truly patient-focused and 
proactive, early patient identification can be guided using disease trajectories, classifications 
and frameworks, such as the AMBER care bundle in acute hospitals and the Gold Standard 
Framework (GSF) developed in primary care (GSF, 2011; Etkind et al, 2015). To help 
professionals identify these patients the AMBER and GSF frameworks ask the following 
surprise question: ‘would you be surprised if the individual patient may die within the next 12 
months?’. This is asked in the understanding that the next 12 months’ journey is likely to be 
unpredictable, but there should be many potential contact points ahead where professionals 
have the time and to plan for these conversations (Thomas et al, 2016; Wright et al, 2018). 
Proactive patient identification contributes to the kind of quality care that is characterised 
by: 
• A person-centred approach 
• Open and honest communication 
• Treating individuals with dignity and respect (Health Education England (HEE), 
2017a) 
The national quality standards for end-of-life care draw on evidence to emphasise that all 
health and social care staff involved in end-of-life care, regardless of professional role, are 
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under a particular expectation to deliver individualised care (Department of Health and Social 
Care (DHSC), 2009; NICE, 2004; Leadership Alliance for Care of Dying People (LACDP), 
2014; Care Quality Commission (CQC), 2016; HEE, 2017b).  
The CQC (2016) reviewed national statistics on the delivery of end-of-life care, finding 
significant inequalities in the care delivered, with reduced access to advance care planning in 
those who were more vulnerable, either through demographics, dementia or dying from 
comorbidities other than cancer. This may mean that, for many dying from liver disease, 
individualised end-of-life care may not be achievable, and their wishes may go unidentified 
and unexplored. To combat these inequalities, missed opportunities need to be reduced, and 
not failing people who may be in their last year of life means identifying them sufficiently early. 
Preferred place of death 
Preferred place of death has historically been a performance indicator in the UK, with PHE’s 
(2017) end-of-life care profiles aiming to reduce the overall number of deaths in acute 
hospitals. This is based on the understanding that most patients would rather die at home than 
in a hospital, and so the acute setting is not the ideal place for end-of-life care. As liver disease 
advances, with increasing symptom burden and severity, crisis points requiring hospital 
admission become more common, which can be very frightening for patients and their families. 
For example, a patient might experience a catastrophic variceal haemorrhage at home, 
necessitating emergency hospital admission for urgent lifesaving treatment and/or symptom 
management. For patients who wish to die at home, hospital admissions can still be 
unavoidable. This patient and/or family can change their minds, and a death in a hospital 
should not be considered a failure, when the patient received high-quality end-of-life care at 
the point of admission. 
Open and honest discussions about treatment plans and symptom management should be 
prepare health professionals and loved ones for a likely death, whether it occurs with or without 
medical intervention and whether or not it happens at home. Professional accountability 
means that among a nurse’s core duties are candour and respect when it comes to balancing 
ethical principles (General Medical Council (GMC), 2010; Nursing and Midwifery Council 
(NMC), 2015).  
In liver disease, therefore, place of death may not necessarily be an appropriate marker for 
whether quality end-of-life care has been achieved. For some patients dying from advancing 
liver disease, hospital may be the best and preferred outcome, and for others it may not be. 
This underlines the need to make sure care is individualised and person-centred. Advancing 
liver disease often comes with rapid deterioration, which presents much uncertainty and 
makes conversations on advance care planning especially important. 
As well as the need to discuss advance care planning, care coordination is essential to 
minimise duplication and ensure information is shared promptly between health professionals. 
Complex needs often require high-quality care in a variety of settings, requiring frequent 
medical attention as death approaches. Therefore, for each patient, will it is necessary to 
identify contacts for advice on palliative care and liver disease, both in and out of hours, as 




Reviewing care plans 
As their illness progresses, liver patients require regular review of care planning, and 
discussions of wishes and preferences. Nurses are in a prime position to have conversations 
with patients and their families about end-of-life care. Tailoring individual emergency care 
plans should ideally involve those health care professionals who know the patient well and 
consider what potential outcomes are most likely. Discussing preferred manner and place of 
death is the cornerstone of modern treatment plans, such as the Recommended Summary 
Plan for Emergency Care and Treatment (ReSPECT) (Pitcher et al, 2017). ReSPECT 
discussions should: 
• Start as early as possible 
• Link in to ongoing conversations 
• Give ample opportunities to discuss possible treatments that can be given—not just 
those that may be withheld, such as resuscitation (ReSPECT Working Group, 
2017). 
Care plans are created through conversations between patients and health professionals, 
covering future care and treatments that they may want or may wish not to have in a future 
emergency. This helps to balance and frame these often-difficult conversations. The 
completed form stays with the patient and is made available to health professionals who called 
in an emergency, either at home or in hospital. It may contain broader goals of individualised 
care and encourages open and honest conversations about future uncertainties, and it 
captures what is important to the patient as he or she approaches potential crisis points and 
dying. Such emergency treatment plans may also contain the discussions and decisions about 
cardiopulmonary resuscitation, along with goals and ceilings of emergency treatment and 
care. To support autonomy and mental capacity assessment, the earlier these conversations 
can be had prior to any cognitive deterioration, the more likely that these open and honest 
conversations can support best-interest decisions when needed at a later point (UK 
Government, 2005). 
Nurse training 
It is of paramount importance to enhance nurses’ skills in dealing with complex end-of-life 
care in patients with liver disease, as nurses are at the heart of providing a person-centred 
and individualised approach to care. Evidence suggests that professionals’ and patients’ 
acknowledgement of death allows sensitive discussions around end-of-life issues and 
concerns (Anderson et al, 2013). While holistic, person-centred care and equal partnership 
working should be at the heart of nurses’ skills and abilities (HEE, 2017a), not all nurses 
always feel either confident or competent when it comes to having these conversations. 
Having identified that nurses caring for liver patients need to be equipped to help support 
many complex situations, attention to providing the underpinning education and training in 
communication skills is essential to increase both confidence and competence in having these 
conversations. Recent developments in conversational analysis have shown that both 
professionals and patients are hesitant to introduce the topic of end-of-life discussions, for 
numerous reasons (Pino and Parry, 2018). During consultations, patients are often reluctant 
to ask for an estimated prognosis or broach the subject of dying, instead waiting for open 
opportunities to appear. Patients can be encouraged by understanding their perspective and 
readiness to hear more (Pino and Parry, 2018). Nurses often fear that raising this topic may 
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not be their role or responsibility, this it is something that all health professionals involved in 
end-of-life care share responsibility for, and nurses are most suitably placed than other 
colleagues, being more likely to know their patients and associated loved ones well. However, 
nurses need to feel confident and have appropriate support and training. Being able to see 
the impact of real patient interactions with regards to end-of-life talk adds both authenticity 
and greater emotional impact to new learning, which can help build confidence (Parry et al, 
2018). 
Conclusion 
Understanding an individual’s personal context, situation and choices, as well as finding 
out what is important to their quality of life, is paramount (HEE, 2017b). Some patients with 
decompensated liver disease may have had a lifestyle that already isolated them from loved 
ones, and, while it is good to identify if patients have important loved ones in their lives, it 
cannot be assumed that everyone has a family, carers or friends, or that they would choose 
anyone to be involved in their lives or their care, and this may or may not be a concern to 
them. What is important for nurses is to identify and recognise an individual’s circumstances 
and focus on a person-centred approach (LACDP, 2014). Where appropriate, nurses can offer 
and signpost to befriending services and community care coordinators, as well as encourage 
engagement in advance care planning and escalation of treatment plans, in order to capture 
patients’ wishes about what is important to them and to make sure they are shared and taken 
into consideration. 
Patients with advanced liver disease, as well as their loved ones, face considerable 
challenges. Nurses are able to support them in managing these challenges by supporting 
quality of life until death and balancing the patients’ preferences and wishes with the need to 
prepare for crisis and the eventuality of death. As such, these patients need anticipatory, 
concordant end-of-life plans to be incorporated into their overall care. 
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